The reduction of tumor necrosis factor-α release and tissue damage by pentobarbital in the experimental endotoxemia model

Shock

Volumn 28, Issue 3, 2007, Pages 309-316

  Yang, Fwu Lin ^a,b   Li, Chi Han ^c   Hsu, Bang Gee ^b,d   Tsai, Nu Man ^e   Lin, Shinn Zong ^a,b   Harn, Horng Jyh ^a,b   Chen, Hsing I ^a   Liao, Kuang Wen ^c   Lee, Ru Ping ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^d Tzu Chi Medicine Center Hospital   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Conscious rats; LPS; Organ injury; Pentobarbital; TNF

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; BACTERIUM LIPOPOLYSACCHARIDE; CREATINE KINASE; DEFEROXAMINE MESYLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NITROGEN; PENTOBARBITAL; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DEATH; CELL VIABILITY; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CYTOKINE RELEASE; CYTOTOXICITY; DRUG EFFECT; EMBRYO; ENDOTOXEMIA; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MONITORING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; TISSUE INJURY; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ANESTHETICS; ANIMALS; ANOXIA; APOPTOSIS; CELL LINE; ENDOTOXEMIA; HUMANS; LIPOPOLYSACCHARIDES; MICE; NF-KAPPA B; PENTOBARBITAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548030028     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/shk.0b013e31803dd04d     Document Type: Article

References (38)

1. Piper RD, Cook DJ, Bone RC, Sibbald WJ: Introducing Critical Appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med 24:2059-2070, 1996.
2. Vincent JL: New therapies in sepsis. Chest 112:330S-338S, 1997.
3. Kotani N, Hashimoto H, Sessler DI, Kikuchi A, Suzuki A, Takahashi S, Muraoka M, Matsuki A: Intraoperative modulation of alveolar macrophage function during isoflurane and propofol anesthesia. Anesthesiology 89:1125-1132, 1998.
4. Kotani N, Hashimoto H, Sessler DI, Yasuda T, Ebina T, Muraoka M, Matsuki A: Expression of genes for proinflammatory cytokines in alveolar macrophages during propofol and isoflurane anesthesia. Anesth Analg 89:1250-1256, 1999.
5. Yokoyama M, Itano Y, Mizobuchi S, Nakatsuka H, Kaku R, Takashima T, Hirakawa M: The effects of epidural block on the distribution of lymphocyte subsets and natural-killer cell activity in patients with and without pain. Anesth Analg 92:463-469, 2001.
6. Livnat S, Felten SY, Carlson SL, Bellinger DL, Felten DL: Involvement of peripheral and central catecholamine systems in neural-immune interactions. J Neuroimmunol 10:5-30, 1985.
7. Landmann RM, Burgisser E, Wesp M, Buhler FR: Beta-adrenergic receptors are different in subpopulations of human circulating lymphocytes. J Recept Res 4:37-50, 1984.
8. Yoshimura T, Kurita C, Nagao T, Usami E, Nakao T, Watanabe S, Kobayashi J, Yamazaki F, Tanaka H, Inagaki N, et al.: Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Pharmacology 54:144-152, 1997.
9. Weiss M, Schneider EM, Tarnow J, Mettler S, Krone M, Teschemacher A, Lemoine H: Is inhibition of oxygen radical production of neutrophils by sympathomimetics mediated via beta-2 adrenoceptors? J Pharmacol Exp Ther 278:1105-1113, 1996.
10. Xu H, Aibiki M, Yokono S, Ogli K: Dose-dependent effects of propofol on renal sympathetic nerve activity, blood pressure and heart rate in urethane-anesthetized rabbits. Eur J Pharmacol 387:79-85, 2000.
11. Greisen J, Hokland M, Grofte T, Hansen PO, Jensen TS, Vilstrup H, Tonnesen E: Acute pain induces an instant increase in natural killer cell cytotoxicity in humans and this response is abolished by local anaesthesia. Br J Anaesth 83:235-240, 1999.
12. Fuentes JM, Talamini MA, Fulton WB, Hanly EJ, Aurora AR, De Maio A: General anesthesia delays the inflammatory response and increases survival for mice with endotoxic shock. Clin Vaccine Immunol 13:281-288, 2006.
13. Loeb AL, Godeny I, Longnecker DE: Anesthetics alter relative contributions of NO and EDHF in rat cremaster muscle microcirculation. Am J Physiol 273:H618-H627, 1997.
14. Nyhan DP, Chen BB, Fehr DM, Rock P, Murray PA: Anesthesia alters pulmonary vasoregulation by angiotensin II and captopril. J Appl Physiol 72:636-642, 1992.
15. Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N, Obara H, Niwa Y: Propofol inhibits human neutrophil functions. Anesth Analg 87:695-700, 1998.
16. Galley HF, Dubbels AM, Webster NR: The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes. Anesth Analg 86:1289-1293, 1998.
17. Chanimov M, Berman S, Weissgarten J, Averbukh Z, Cohen M, Grinshpun Y, Bahar M: Substances used for local and general anaesthesia in major surgery suppress proliferative responsiveness of normal rat peripheral blood mononuclear cells in culture. Eur J Anaesthesiol 17:248-255, 2000.
18. Chou WC, Liao KW, Lo YC, Jiang SY, Yeh MY, Roffler SR: Expression of chimeric monomer and dimer proteins on the plasma membrane of mammalian cells. Biotechnol Bioeng 65:160-169, 1999.
19. Lee RP, Wang D, Lin NT, Chen HI: Physiological and chemical indicators for early and late stages of sepsis in conscious rats. J Biomed Sci 9:613-621, 2002.
20. Gao J, Zeng B, Zhou L: The protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats. Middle East J Anesthesiol 17:379-401, 2003.
21. Gao J, Zeng BX, Zhou LJ, Yuan SY: Protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats. Br J Anaesth 92:277-279, 2004.
22. Joung YH, Lim EJ, Lee MY, Park JH, Ye SK, Park EU, Kim SY, Zhang Z, Lee KJ, Park DK, et al.: Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells. Exp Mol Med 37:353-364, 2005.
23. Lee MY, Hee Joung Y, Joung Lim E, Park JH, Ye SK, Park T, Zhang Z, Ki Park D, Jeon Lee K, Yang YM: Phosphorylation and activation of STAT proteins by hypoxia in breast cancer cells. Breast 15:187-195, 2005.
24. Morimoto Y, Nishihira J, Kemmotsu O, Shibano T, Gando S, Shikama H: Pentobarbital inhibits apoptosis in neuronal cells. Crit Care Med 28:1899-1904, 2000.
25. Kotani N, Takahashi S, Sessler DI, Hashiba E, Kubota T, Hashimoto H, Matsuki A: Volatile anesthetics augment expression of proinflammatory cytokines in rat alveolar macrophages during mechanical ventilation. Anesthesiology 91:187-197, 1999.
26. Gotsch U, Jager U, Dominis M, Vestweber D: Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo. Cell Adhes Commun 2:7-14, 1994.
27. Shi Q, Wang J, Wang XL, VandeBerg JL: Comparative analysis of vascular endothelial cell activation by TNF-alpha and LPS in humans and baboons. Cell Biochem Biophys 40:289-304, 2004.
28. Myers CL, Wertheimer SJ, Schembri-King J, Parks T, Wallace RW: Induction of ICAM-1 by TNF-alpha, IL-1 beta, and LPS in human endothelial cells after downregulation of PKC. Am J Physiol 263:C767-C772, 1992.
29. - production by neutrophil-endothelial cell interaction via CD11b: its modulation by tumor necrosis factor-alpha (TNF-alpha) and lipopolysaccharide (LPS). Int J Hematol 65:49-59, 1996.
30. Miller LS, Morita Y, Rangan U, Kondo S, Clemens MG, Bulkley GB: Suppression of cytokine-induced neutrophil accumulation in rat mesenteric venules in vivo by general anesthesia. Int J Microcirc Clin Exp 16:147-154, 1996.
31. Timokhov VS, Iakovleva II, Kalashnikova EA, Ipat'eva EI: Plasma contents of cytokines (TNF-alpha, IL-1 beta, IL-6) and their clearence during continuous hemofiltration in patients with sepsis and multiple organ failure. Anesteziol Reanimatol 3:59-62, 1997. [in Russian].
32. Grundmann HJ, Hahnle U, Hegenscheid B, Sahlmuller G, Bienzle U, Blitstein-Willinger E: Inhibition of endotoxin-induced macrophage tumor necrosis factor expression by a prostacyclin analogue and its beneficial effect in experimental lipopolysaccharide intoxication. J Infect Dis 165:569-573, 1992.
33. Bertini R, Delgado R, Faggioni R, Gascon MP, Ythier A, Ghezzi P: Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock. Eur Cytokine Netw 4:39-42, 1993.
34. Read MA, Cordle SR, Veach RA, Carlisle CD, Hawiger J: Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci U S A 90:9887-9891, 1993.
35. Nick JA, Avdi NJ, Young SK, Lehman LA, McDonald PP, Frasch SC, Billstrom MA, Henson PM, Johnson GL, Worthen GS: Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest 103:851-858, 1999.
36. Chen LW, Huang HL, Lee IT, Hsu CM, Lu PJ: Thermal injury-induced priming effect of neutrophil is TNF-alpha and P38 dependent. Shock 26:69-76, 2006.
37. Penner CG, Gang G, Wray C, Fischer JE, Hasselgren PO: The transcription factors NF-kappab and AP-1 are differentially regulated in skeletal muscle during sepsis. Biochem Biophys Res Commun 281:1331-1336, 2001.
38. Taniguchi T, Yamamoto K: Anti-inflammatory effects of intravenous anesthetics on endotoxemia. Mini Rev Med Chem 5:241-245, 2005.